Home » Archive by Tags

Articles tagged with: ALTH

Allos Therapeutics Offering (NASDAQ:ALTH)
October 8, 2009 – 9:00 am | No Comment

Allos Therapeutics has announced on Wednesday morning that they will be expanding the share offerings and will now sell around 14 million shares for $7.10 per share. On Monday, Allos Therapeutics has already announced that …

Folotyn drug gets FDA approval (Nasdaq:ALTH)
September 28, 2009 – 10:10 am | No Comment

Allos Therapeutics Inc (Nasdaq:ALTH)┬ámust be delighted with joy after getting a green signal by the FDA panel for their injectable drug Folotyn, which will be used for the treatment of peripheral T-cell lymphoma, a rare …